News Releases
May 16, 2017
Synlogic and Mirna Investor Conference Call Information
May 16, 2017
Synlogic and Mirna Therapeutics Agree to Merger
March 23, 2017
Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting
December 15, 2016
Synlogic Appoints COO and Head of Corporate Development
November 10, 2016
Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia
September 12, 2016
Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic
August 29, 2016
Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation
March 23, 2016
Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors
February 17, 2016
Synlogic Secures $40 Million in Series B Financing
February 10, 2016
Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome
January 5, 2016
Synlogic to Present at the 34th Annual J.P. Morgan Healthcare Conference
September 17, 2015
Synlogic Accelerates Business Growth with Appointment of President, Expansion of Financing, and an Industry Collaboration
Displaying 121 - 132 of 136